Comprehensive biomarker and modeling approach to support dose finding for BI 836880, a VEGF/Ang-2 inhibitor

Abstract Background BI 836880 is a humanized bispecific nanobody® that binds to and blocks vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2). A comprehensive biomarker and modeling approach is presented here that supported dose finding for BI 836880. Methods Two Phase I dose-escal...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Sascha Keller, Ulrich Kunz, Ulrike Schmid, Jack Beusmans, Martin Büchert, Min He, Girish Jayadeva, Christophe Le Tourneau, Doreen Luedtke, Heiko G. Niessen, Zohra Oum’hamed, Sina Pleiner, Xiaoning Wang, Ralph Graeser
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2024-10-01
Ráidu:	Journal of Translational Medicine
Fáttát:	BI 836880 Biomarkers VEGF Ang-2 Pharmacokinetics Pharmacodynamics
Liŋkkat:	https://doi.org/10.1186/s12967-024-05612-x
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!